2 Result: Dry Eye Disease
Shire's First Prescription Eye Drop, Xiidra(TM) (lifitegrast ophthalmic solution) 5% Is Now Available in the U.S.
August 29th, 2016
Xiidra is the onlyprescription eye drop approved by the U.S. FDA for the treatment of both signs and symptoms of dry eye disease Resources are available to support patients seeking information regarding coverage and savings offers Xiidra is t. Read more
Shire Receives FDA Complete Response Letter for Lifitegrast NDA and Plans to Respond with OPUS-3 Trial
October 18th, 2015
Topline results from OPUS-3 Trial expected before year-end Lexington, Mass. / CRWEPRESSRELEASE / October 16, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the U.S. Food and Drug Administration (FDA) requested an additio. Read more
Want To Find Some News?
News By Industries
February 20th, 2019January 09th, 2019January 09th, 2019December 19th, 2018